TY - CONF T1 - Efficacy and Safety of Co-Formulated Ombitasvir/Paritaprevir/Ritonavir with Ribavirin in Adults with Chronic HCV Genotype 4 Infection in Egypt (AGATE-II) [Abstract 708] T2 - 66th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), November 13-17, 2015 Y1 - 2015 A1 - Gamal E. Esmat A1 - Wahid H. Doss A1 - Roula B. Qaqish A1 - Imam Waked A1 - Gamal E. Shiha A1 - Ayman Yosry A1 - Mohamad Hassany A1 - Jennifer King A1 - Coleen Hall A1 - Rebecca Redman A1 - Niloufar Mobashery AB -

708

JA - 66th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), November 13-17, 2015 CY - San Francisco, CA ER -